⚠ BETA β€” all market data shown (deals, filings, prices, indices) is demo / illustrative, not live trading data. For evaluation only; verify before acting.
June 17, 2026

NSE

Krishna Institute of Medical Sciences LimitedKIMS

Nifty Smallcap 250

Krishna Institute of Medical Sciences Limited (KIMS) is a healthcare provider in India, known for its medical education and research facilities.

Key productsMedical education, healthcare services
GeographyIndia
CompetitorsManipal Education & Healthcare, Apollo Hospitals Enterprises

AI-generated overview β€” verify before relying on it.

Net institutional flow

+β‚Ή0 Cr

Institutional buyers

1 in / 1 out

High-impact filings

1 Β· tilt Neutral

Next corporate action

β€”

Competitive landscape β€” the read

vs mapped peers Β· 1M
No meaningful institutional flow across this set yet β€” comparison is on filings, buzz and activity. News & social buzz is most positive on ACUTAAS.
#CompanyInst. flow β‚ΉCrDealsHi-impactFiling mom.BuzzNews
1KIMSThisβ€”β€”1β€”β€”β€”
2ACMESOLARβ€”β€”β€”β€”+36
3AADHARHFCβ€”β€”β€”β€”β€”β€”
4AARTIINDβ€”β€”β€”β€”β€”β€”
5AAVASβ€”β€”β€”β€”β€”β€”
6ACEβ€”β€”β€”β€”β€”β€”
7ACUTAASβ€”β€”β€”β€”+46
8ABFRLβ€”β€”β€”β€”β€”β€”
9ABLBLβ€”β€”β€”β€”β€”β€”

Ranked by net institutional flow (buys βˆ’ sells, β‚ΉCr). Filing momentum = bullish βˆ’ bearish filings; Buzz = news+social sentiment. Curate peers in the company admin.

Timeline β€” KIMS day by day

Merged from deals, filings, corporate actions and news β€” newest first. Compact rolls each day up to net flow + counts. Scope with the range above.

Filings that matter

  • 2
    GeneralNeutral

    Qualified institutions placement of equity shares of face value ₹

    Source PDF β†’
  • 7
    ResultsNeutral

    Audited FY26 results likely provide a clear financial health snapshot.

    Source PDF β†’
  • 2
    Board MeetingNeutral

    Board meeting outcome routine; no significant share-price impact.

    Source PDF β†’
  • 2
    Shareholding DisclosureNeutral

    a copy of Disclosure under Regulation 31(4) read with Regulation 31(5) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.

    Source PDF β†’

Bulk & block deals

No bulk/block deals for KIMS in this window.

Results & transcripts

News & chatter on KIMS

RSS News

0

No recent news.

Google News RSS β€” links open the source.

Investdesk

0

No articles yet.

Our coverage.

Reddit

0

No Reddit chatter.

r/ posts mentioning the company.

Twitter / X

0

No posts.

Posts mentioning the company.